Sargent Bickham Lagudis’s Sanofi SNY Stock Holding History

Sargent Bickham Lagudis’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$11.9K	Hold	246	–	–	﹤0.01%	704
2022 Q3	$9K	Hold	246	–	–	﹤0.01%	711
2022 Q2	$12K	Buy	+246	New	+$13.1K	﹤0.01%	673
2020 Q1	–	Sell	-99	Closed	-$5K	–	903
2019 Q4	$5K	Sell	99 -11	-10%	-$515	﹤0.01%	698
2019 Q3	$5K	Buy	110 +10	+10%	+$431	﹤0.01%	631
2019 Q2	$4K	Hold	100	–	–	﹤0.01%	680
2019 Q1	$4K	Hold	100	–	–	﹤0.01%	714
2018 Q4	$4K	Hold	100	–	–	﹤0.01%	684
2018 Q3	$4K	Buy	+100	New	+$4.27K	﹤0.01%	705
2016 Q4	–	Sell	-262	Closed	-$10K	–	747
2016 Q3	$10K	Buy	+262	New	+$10.5K	﹤0.01%	583

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Sargent Bickham Lagudis's SNY Position: Q4 2022 in Review

Sargent Bickham Lagudis held its Sanofi (SNY) position steady in Q4 2022 at 246 shares worth $11.9K. The position accounts for ﹤0.01% of the portfolio, ranked #704.

Sargent Bickham Lagudis first reported a position in SNY in Q3 2016 and has held it in 10 quarters since. The position peaked at $12K in Q2 2022. 643 funds tracked by Wall St. Rank hold SNY as of Q4 2022.

Sargent Bickham Lagudis held 246 shares of Sanofi worth $11.9K as of Q4 2022.
Sargent Bickham Lagudis left its Sanofi share count unchanged in Q4 2022.
Sanofi made up ﹤0.01% of Sargent Bickham Lagudis's portfolio in Q4 2022, its #704 holding.
Sargent Bickham Lagudis first reported a position in Sanofi in Q3 2016 and has held it in 10 quarters since.
Sargent Bickham Lagudis's Sanofi position peaked at $12K in Q2 2022.
643 funds tracked by Wall St. Rank held Sanofi as of Q4 2022.

Based on Sargent Bickham Lagudis's 13F filing for Q4 2022, filed 23 Jan 2023.